MOUNJARO — ELI LILLY AND CO, approved 2026-01-20 (NDA215866).
124,414 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.